New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Quest Diagnostics Incorporated
DGX
Shape
US Flag

NYSE

18B

Medical - Diagnostics & Research

Next Earning date - 22 Oct 2024

18B

Medical - Diagnostics & Research

Next Earning date - 22 Oct 2024

157.47USD
Shape10.10 ( 6.85%)
favorite-chart

Relative Strenght

64
favorite-chart

Volume Buzz

134%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated October 22, 2024
1W 5.77 % 1M 2.81 % 3M 12.30 % 1Y 32.50 %

Key Metrics

Shape
  • Market Cap

    17.53B


  • Shares Outstanding

    111.32M


  • Share in Float

    110.77M


  • Dividende

    3


  • Earning Date

    22 Oct 2024


  • Price Target

    157.47


  • Average Volume

    772750


  • Beta

    0.888


  • Range

    120.87-159.36


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.questdiagnostics.com


  • Sector

    Healthcare


Fundamentals

Shape

12.85x

P/E Ratio

1.84x

P/S Ratio

2.57x

P/B Ratio

1.0

Debt/Equity

13.2%

Net Margin

$7.4

EPS

How DGX compares to sector?

P/E Ratio

Relative Strength

Shape

DGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10B

Shape315%

2025-Revenue

$8.77

Shape52%

2025-EPS

$2B

Shape1478%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Neutral

2024-07-10

Now: Buy

Credit Suisse

downgrade

Previous: Not converted

2023-04-03

Now: Neutral

Goldman Sachs

upgrade

Previous: Not converted

2023-04-03

Now: Buy

Barclays

downgrade

Previous: Not converted

2023-04-03

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-41%

1.98
vs 3.33

Q1.23

arrow
arrow

-37%

2.04
vs 3.22

Q2.23

arrow
arrow

-3%

2.3
vs 2.36

Q3.23

arrow
arrow

-6%

2.22
vs 2.36

Q4.23

arrow
arrow

+9%

2.15
vs 1.98

Q1.24

arrow
arrow

N/A

2.04
vs 2.04

Q2.24

arrow
arrow

+2%

2.35
vs 2.3

Q3.24

arrow
arrow

+158%

5.72
vs 2.22

Q4.24

arrow
arrow

+4%

2.23
vs 2.15

Q1.25

arrow
arrow

+9%

2.22
vs 2.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-15%

2.3B  vs 2.7B

Q1.23

arrow
arrow

-11%

2.3B  vs 2.6B

Q2.23

arrow
arrow

-5%

2.3B  vs 2.5B

Q3.23

arrow
arrow

-8%

2.3B  vs 2.5B

Q4.23

arrow
arrow

-2%

2.3B  vs 2.3B

Q1.24

arrow
arrow

+2%

2.4B  vs 2.3B

Q2.24

arrow
arrow

+3%

2.4B  vs 2.3B

Q3.24

arrow
arrow

+8%

2.5B  vs 2.3B

Q4.24

arrow
arrow

+8%

2.5B  vs 2.3B

Q1.25

arrow
arrow

+7%

2.5B  vs 2.4B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+2%

0.02
vs 0.04

Q1.23

arrow
arrow

+3%

0.03
vs 0.02

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.04

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Q3.24

arrow
arrow

+9%

0.09
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

818

818
vs 864

-5%

Q4.22

arrow
arrow

901

901
vs 818

10%

Q1.23

arrow
arrow

846

846
vs 901

-6%

Q2.23

arrow
arrow

833

833
vs 846

-2%

Q3.23

arrow
arrow

815

815
vs 833

-2%

Q4.23

arrow
arrow

842

842
vs 815

3%

Q1.24

arrow
arrow

825

825
vs 842

-2%

Q2.24

arrow
arrow

835

835
vs 825

1%

Earnings Growth

Latest News